StayCurrentMD · Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma
Follow
Video1 min·Published Jan 2026

Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma

hosted by Dr. Sophia Schermerhorn · StayCurrentMD
Try
Intelligent Search· scoped to neuroblastoma · not medical adviceSearch the whole library →

More about neuroblastoma

same diagnosisDive deeper → Neuroblastoma (26 items)
Video
Hepatoblastoma with Dr. Greg Tiao
CCHMC Pediatric Surgery · Published Mar 2022
Podcast
Hepatoblastoma with Dr. Greg Tiao
10 min · Published Feb 2022
Video
Long-Term Follow-Up of Surgical Outcomes for Patients With Wilms Tumor and Neuroblastoma
1 min · Published Feb 2026
Video
Update Course Rewind: Staging and Management of Neuroblastoma 2022
Published Jun 2023
Video
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report
59 s · Published Mar 2026
Video
Image-guided core-needle or surgical biopsy for neuroblastoma diagnosis in children
54 s · Published Feb 2024

More from StayCurrentMD

same institutionDive deeper → StayCurrentMD
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
What the experts said8 expert statements
Study was a retrospective analysis of 12,000 patients with neuroblastoma, Wilms tumor, and hepatoblastoma from the National Cancer Database
EpidemiologicalSophia Schermerhorn
Socioeconomic disadvantage score was created for each patient based on median household income and education level in their local communities
EpidemiologicalSophia Schermerhorn
The most disadvantaged children were more likely to have worse survival for Wilms tumor and neuroblastoma
EpidemiologicalSophia Schermerhorn
After adjusting for tumor size, grade, treatment, and comorbidities, socioeconomic effects on survival remained present
EpidemiologicalSophia Schermerhorn
Hazard ratio for socioeconomic disadvantage was 2.02 for Wilms tumor
EpidemiologicalSophia Schermerhorn
Hazard ratio for socioeconomic disadvantage was 1.29 for hepatoblastoma
EpidemiologicalSophia Schermerhorn
Pediatric oncology outcomes depend on tumor biology, treatment received, and social determinants of health
OpinionSophia Schermerhorn
Identifying socioeconomic risk factors is necessary to close equity gaps and improve survival for all children with solid tumors
OpinionSophia Schermerhorn